In patients with comorbidities, the ANG-1, VEGF, PF-4, and TAC-1 genes clustered more closely in tumor tissue than in platelets (37.4% and 15.8% of the variance of PC1 and PC2). This evidence concerns the gene TAC1 and neoplasm.